市場調查報告書
商品編碼
1387451
僵直性脊椎炎治療市場報告:2030 年趨勢、預測與競爭分析Ankylosing Spondylitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
僵直性脊椎炎治療的趨勢與預測
預計到 2030 年,全球僵直性脊椎炎治療市場將達到 84 億美元,2024 年至 2030 年年複合成長率為 6.5%。這個市場的主要促進因素是僵直性脊椎炎盛行率的上升、對該疾病的認知和診斷的提高以及僵直性脊椎炎治療的進步。全球僵直性脊椎炎治療市場前景廣闊,醫院藥局、零售藥局和線上藥局市場充滿機會。
僵直性脊椎炎治療市場洞察
Lucintel 預測,由於僵直性脊椎炎的成長,非類固醇抗發炎藥物在預測期內將繼續佔據很大一部分。
由於零售藥局數量不斷增加且患者更容易進入,因此零售藥局仍然是市場上最大的部分。
由於老年人口不斷成長和政府的支持措施,北美在預測期內可能仍然是最大的地區。
Ankylosing Spondylitis Treatment Trends and Forecast
The future of the global ankylosing spondylitis treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global ankylosing spondylitis treatment market is expected to reach an estimated $8.4 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurence of ankylosing spondylitis, growing awareness and diagnosis of condition, and advancement in ankylosing spondylitis therapy.
A more than 150-page report is developed to help in your business decisions.
Ankylosing Spondylitis Treatment by Segment
The study includes a forecast for the global ankylosing spondylitis treatment by drug class, distribution channel, and region.
Ankylosing Spondylitis Treatment Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
Ankylosing Spondylitis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
Ankylosing Spondylitis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Ankylosing Spondylitis Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ankylosing spondylitis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ankylosing spondylitis treatment companies profiled in this report include-
Ankylosing Spondylitis Treatment Market Insights
Lucintel forecasts that NSAIDs will remain the larger segment over the forecast period due to growth of ankylosing spondylitis.
Within this market, retail pharmacy will remain the largest segment due to growing number of retail pharmacies and it is easy to reach for patients.
North America will remain the largest region over the forecast period due to growth of geriatric population and supportive government initiatives.
Features of the Global Ankylosing Spondylitis Treatment Market
Market Size Estimates: Ankylosing spondylitis treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Ankylosing spondylitis treatment market size by drug class, distribution channel, and region in terms of value ($B).
Regional Analysis: Ankylosing spondylitis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug classes, distribution channels, and regions for the ankylosing spondylitis treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ankylosing spondylitis treatment market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the ankylosing spondylitis treatment market size?
Answer: The global ankylosing spondylitis treatment market is expected to reach an estimated $8.4 billion by 2030.
Q2. What is the growth forecast for ankylosing spondylitis treatment market?
Answer: The global ankylosing spondylitis treatment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the ankylosing spondylitis treatment market?
Answer: The major drivers for this market are rising occurence of ankylosing spondylitis, growing awareness and diagnosis of condition, and advancement in ankylosing spondylitis therapy.
Q4. What are the major segments for ankylosing spondylitis treatment market?
Answer: The future of the ankylosing spondylitis treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.
Q5. Who are the key ankylosing spondylitis treatment market companies?
Answer: Some of the key ankylosing spondylitis treatment companies are as follows:
Q6. Which ankylosing spondylitis treatment market segment will be the largest in future?
Answer: Lucintel forecasts that NSAIDs will remain the larger segment over the forecast period due to growth of ankylosing spondylitis.
Q7. In ankylosing spondylitis treatment market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growth of geriatric population and supportive government initiatives.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.